Zoe X Malchiodi

6PUBLICATIONS
25CO-AUTHORS
Predictive and prognostic markersCancer therapy (excl. chemotherapy and radiation therapy)Molecular targetsCancer cell biologyCancer genetics
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (6)

|Jul 24, 2026
Periductal Fibroblast Density Defines Lymphocyte Exclusion via a CD44-Dependent Stromal Checkpoint in Pancreatic Cancer.

|Jun 10, 2024
Periductal Fibroblast Density Defines Lymphocyte Exclusion via a CD44-Dependent Stromal Checkpoint in Pancreatic Cancer.

Zoe X Malchiodi, Alexander A Lekan, Robert K Suter

|Oct 13, 2021
Cholecystokinin Receptor Antagonist Improves Efficacy of Chemotherapy in Murine Models of Pancreatic Cancer by Altering the Tumor Microenvironment.

Zoe X Malchiodi, Hong Cao, Martha D Gay

|Jan 29, 2021
Antitumor T-cell Immunity Contributes to Pancreatic Cancer Immune Resistance.

Reham Ajina, Zoe X Malchiodi, Allison A Fitzgerald

|Jan 27, 2021
Understanding and Targeting Natural Killer Cell-Cancer-Associated Fibroblast Interactions in Pancreatic Ductal Adenocarcinoma.

Zoe X Malchiodi, Louis M Weiner

|Oct 29, 2020
Targeting the Cholecystokinin Receptor: A Novel Approach for Treatment and Prevention of Hepatocellular Cancer.

Martha D Gay, Anita Safronenka, Hong Cao

Pageof 1

Frequent Collaborators

5 joint publications

Louis M Weiner

4 joint publications

Sandra A Jablonski

3 joint publications

Elana J Fertig

3 joint publications

Won Jin Ho